Aphria Inc. (TSX:APHA) agreed to acquire CC Pharma GmbH for €48 million on November 5, 2018. As part of the consideration, Aphria will pay €24.5 million in cash to CC Pharma at closing, with an earn-out multiple on future EBITDA of up to another €23.5 million following closing, if certain performance milestones are met. The deal is expected to close in January 2019. Aphria Inc. (TSX:APHA) completed the acquisition of CC Pharma GmbH for €42.4 million on January 9, 2019. As reported, Aphria paid €18.92 million in cash to the former shareholders of CC Pharma with an earn-out multiple on future EBITDA of up to another €23.5 million, if certain performance milestones are met. Following the acquisition, CC Pharma team and the pharmacists they serve will join the Aphria family.